JPS6124578A - 新規モルホリノール化合物 - Google Patents

新規モルホリノール化合物

Info

Publication number
JPS6124578A
JPS6124578A JP14762385A JP14762385A JPS6124578A JP S6124578 A JPS6124578 A JP S6124578A JP 14762385 A JP14762385 A JP 14762385A JP 14762385 A JP14762385 A JP 14762385A JP S6124578 A JPS6124578 A JP S6124578A
Authority
JP
Japan
Prior art keywords
compound
salt
formula
morpholinol
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP14762385A
Other languages
English (en)
Japanese (ja)
Inventor
ナリマン　ボマンシヨウ　メタ
トーマス　エドガー　スマイサー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of JPS6124578A publication Critical patent/JPS6124578A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP14762385A 1984-07-05 1985-07-04 新規モルホリノール化合物 Pending JPS6124578A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8417170 1984-07-05
GB848417170A GB8417170D0 (en) 1984-07-05 1984-07-05 Heterocyclic pharmaceutical compounds

Publications (1)

Publication Number Publication Date
JPS6124578A true JPS6124578A (ja) 1986-02-03

Family

ID=10563453

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14762385A Pending JPS6124578A (ja) 1984-07-05 1985-07-04 新規モルホリノール化合物

Country Status (12)

Country Link
EP (1) EP0170430A1 (2)
JP (1) JPS6124578A (2)
KR (1) KR860001083A (2)
AU (1) AU4459585A (2)
DK (1) DK307385A (2)
ES (1) ES8609286A1 (2)
FI (1) FI852657A7 (2)
GB (1) GB8417170D0 (2)
GR (1) GR851645B (2)
HU (1) HUT39437A (2)
IL (1) IL75720A0 (2)
ZA (1) ZA855072B (2)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013530144A (ja) * 2010-05-21 2013-07-25 リサーチ・トライアングル・インスティチュート 薬物依存を処置するためのヒドロキシブプロピオン類似体（政府支援研究または開発）

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8924528D0 (en) * 1989-10-31 1989-12-20 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
US7098206B2 (en) 1998-01-21 2006-08-29 Smithkline Beecham Corporation Pharmaceutically active morpholinol
BR9907203A (pt) 1998-01-21 2000-10-17 Glaxo Group Ltd "composto, composições farmacêuticas, uso de um composto, e, processo de tratametno de depressão, distúrbio de hiperatividade por deficiência de atenção (adhd), obesidade, enxaqueca, dor, disfunção sexual, doença de parkinson, doença de alzeheimer, ou vìcio de cocaìna ou de produtos contendo nicotina (especialmente tabaco) em um indivìduo animal ou humano. "
US6998400B2 (en) 1998-01-22 2006-02-14 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6855820B2 (en) 1999-01-20 2005-02-15 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6734213B2 (en) 1999-01-20 2004-05-11 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US7241805B2 (en) 2005-06-27 2007-07-10 Biovail Laboratories, Inc. Modified release formulations of a bupropion salt
KR101014438B1 (ko) * 2008-09-26 2011-02-14 동아제약주식회사 탁산 유도체의 제조방법
CA2800220C (en) 2010-05-21 2019-04-30 Research Triangle Institute Phenylmorpholines and analogues thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117967A (en) * 1962-04-02 1964-01-14 Smith Kline French Lab 2-biphenylyl-2-hydroxy-morpholinium halides
FR2553413B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013530144A (ja) * 2010-05-21 2013-07-25 リサーチ・トライアングル・インスティチュート 薬物依存を処置するためのヒドロキシブプロピオン類似体（政府支援研究または開発）

Also Published As

Publication number Publication date
ES8609286A1 (es) 1986-07-16
GB8417170D0 (en) 1984-08-08
EP0170430A1 (en) 1986-02-05
KR860001083A (ko) 1986-02-22
DK307385A (da) 1986-01-06
ES544862A0 (es) 1986-07-16
FI852657L (fi) 1986-01-06
HUT39437A (en) 1986-09-29
AU4459585A (en) 1986-01-09
FI852657A7 (fi) 1986-01-06
FI852657A0 (fi) 1985-07-04
DK307385D0 (da) 1985-07-04
GR851645B (2) 1985-11-26
IL75720A0 (en) 1985-11-29
ZA855072B (en) 1987-02-25

Similar Documents

Publication Publication Date Title
US3424761A (en) 3-ureidopyrrolidines
US3424760A (en) 3-ureidopyrrolidines
EP0302416B1 (en) 2-nitroimidazole derivatives useful as radiosensitizers for hypoxic tumor cells
JPS61233654A (ja) Ｎ‐（２アミノ脂環式族）‐アリールアシルアミド及びその製法
US4002766A (en) Antiarrhythmia methods
US3732247A (en) 3-di-substituted methylene pyrrolidines wherein the 1-or n-lower-alkyl substituent contains at least two carbon atoms
JPH07502512A (ja) アミジノ誘導体およびその一酸化窒素シンターゼ阻害剤としての使用
JPH0150700B2 (2)
JPS61100562A (ja) １‐（アミノアルキル）α，α‐ジアリールピロリジン‐ピペリジン‐及びホモピペリジン‐アセトアミド並びにアセトニトリル
JPH0324080A (ja) Ｎ‐ヘテロアリール‐プリン‐６‐アミンおよびその製法
US3752823A (en) N alkyl tetrahydrocarbazoles
EP0170430A1 (en) Heterocyclic pharmaceutical compounds, preparation and use
CA1166637A (en) Piperazine derivatives, a process for producing the same and a medicine containing the same
PT100415B (pt) Novas morfolinas de accao farmaceutica, e processo para a sua preparacao
JPH03206084A (ja) 複素環薬剤化合物及びその調製法と用途
US3479370A (en) Esters of 1-substituted-3-disubstituted-pyrrolidinemethanols
JPS6117544A (ja) 新規化合物，その製造方法及び用途
US3458635A (en) Compositions containing 3-di-substituted methylene pyrrolidines and methods of treating depression
US3789125A (en) Pharmaceutical compositions containing halo-substituted 2-amino-benzylamine-amides
US5438057A (en) Pharmaceutical compositions
US3856790A (en) Cyclic amides of 1,4-diaminobut-2-yne
IE45384B1 (en) Method of treating allergy
EP0213506B1 (en) Saturated cycloalkyl[c]pyrrole-2(1H)-acetic acid amides and derivatives thereof
US3626067A (en) Substituted oxazolines, useful as pharmaceuticals
US3492351A (en) 1-(lower alkoxy-phenyl)-2-(lower alkyl-amino)- alkanones-(1) and salts